small molecule

DIACOMIT

STIRIPENTOL

Loss of exclusivityJuly 2029FDA regulatory exclusivity expiry
CompanyBiocodexView the full company profile on CliffBio

Drug detail

Brand nameDIACOMIT
Active ingredientSTIRIPENTOL
Strength500MG/PACKET
Dosage formFOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2018
Marketing statusRX

Regulatory exclusivity

CodeExpires
ODE-403July 2029

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

Not found